retatrutide clinical trial safety How to Get in 2026 Important Safety Notice Retatrutide is

CagriSema and Retatrutide are investigational compounds and are not FDA-approved for human treatment as described here

The GLORY-1 trial was a Phase 3 study published in the New England Journal of Medicine

El frmaco tiene un efecto neutral sobre la glucemia, por lo que no se trata de un frmaco para la diabetes mellitus tipo 2, siendo su objetivo inicial la obesidad y la esteatosis heptica no alcohlica (donde se estn estudiando los beneficios de los ar-GLP1, entre otros)

The decision should be made in consultation with your GP or specialist weight management service based on your individual circumstances

Something went wrong, but dont fret lets give it another shot

Because of this triple action, retatrutide is being studied as a highly effective option for people struggling to lose weight